
Sign up to save your podcasts
Or
Derek Maetzold, CEO of Castle Biosciences shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Castle is leveraging its expertise in cancer genomics and the use of artificial intelligence to improve patient outcomes.
5
77 ratings
Derek Maetzold, CEO of Castle Biosciences shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Castle is leveraging its expertise in cancer genomics and the use of artificial intelligence to improve patient outcomes.
1,071 Listeners
31 Listeners
275 Listeners
309 Listeners
339 Listeners
388 Listeners
124 Listeners
323 Listeners
196 Listeners
83 Listeners
86 Listeners
431 Listeners
145 Listeners
17 Listeners
73 Listeners